Cameron J C, Allan G, Johnston F, Finn A, Heath P T, Booy R
Health Protection Scotland, Glasgow G3 7LN, Scotland, UK.
Arch Dis Child. 2007 Dec;92(12):1062-6. doi: 10.1136/adc.2007.123232. Epub 2007 Nov 8.
To estimate the annual incidence of hospitalisations due to severe complications of varicella, describe the complications and estimate annual mortality.
Active surveillance throughout the UK and Ireland for 13 months by paediatricians notifying cases to the British Paediatric Surveillance Unit and completing a questionnaire. The case definition was any child aged <16 years hospitalised with complicated varicella, as defined by a list of conditions, or admitted to ICU/HDU with varicella.
188 cases were notified for the surveillance period, of which 112 (0.82/100 000 children/year) met the case definition and were not duplicates. Confirmed cases had a median age of 3 years (range 0-14). The complications were: bacteraemia/septic shock (n = 30), pneumonia (n = 30), encephalitis (n = 26), ataxia (n = 25), toxic shock syndrome/toxin-mediated disease (n = 14), necrotising fasciitis (n = 7), purpura fulminans/disseminated coagulopathy (n = 5), fulminant varicella (n = 5) and neonatal varicella (n = 3). 52 children (46%) had additional bacterial infections. Six deaths were due, or possibly due, to varicella, including one intrauterine death. Four of the other five children who died (ages 2-14 years) had a pre-existing medical condition. Sequelae on discharge were reported for 41 cases (40%), most frequently ataxia or skin scarring. The median length of hospital stay was 7 days (range 1-68).
This study provides a minimum estimate of severe complications and death resulting from varicella in children in the UK and Ireland. Most complications, excluding deaths, occur in otherwise healthy children and thus would be preventable only through a universal childhood immunisation programme.
评估水痘严重并发症导致的住院年发病率,描述并发症情况并估算年死亡率。
英国和爱尔兰的儿科医生进行了为期13个月的主动监测,向英国儿科监测单位报告病例并填写问卷。病例定义为任何年龄小于16岁因水痘并发症住院的儿童(根据一系列病症定义),或因水痘入住重症监护病房/高依赖病房的儿童。
监测期间共报告了188例病例,其中112例(每年每10万名儿童中有0.82例)符合病例定义且无重复。确诊病例的中位年龄为3岁(范围0 - 14岁)。并发症包括:菌血症/感染性休克(n = 30)、肺炎(n = 30)、脑炎(n = 26)、共济失调(n = 25)、中毒性休克综合征/毒素介导疾病(n = 14)、坏死性筋膜炎(n = 7)、暴发性紫癜/弥散性血管内凝血(n = 5)、暴发性水痘(n = 5)和新生儿水痘(n = 3)。52名儿童(46%)有其他细菌感染。6例死亡归因于或可能归因于水痘,包括1例宫内死亡。其他5例死亡儿童(年龄2 - 14岁)中有4例有基础疾病。41例(40%)病例出院时有后遗症报告,最常见的是共济失调或皮肤瘢痕。住院中位时长为7天(范围1 - 68天)。
本研究提供了英国和爱尔兰儿童水痘导致的严重并发症和死亡的最低估算值。除死亡外,大多数并发症发生在原本健康的儿童中,因此只有通过普遍的儿童免疫计划才能预防。